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ABSTRACT 
 
 
Morphine is one of the most commonly prescribed medications for the relief of prolonged pain.  
Both basic science and clinical studies indicate that females require 2-3 times more morphine 
than males to achieve the same analgesic effect. To date, the mechanisms underlying sex 
differences in opiate responsiveness are unknown. Recent studies suggest that glial cells are 
potent modulators of morphine-based analgesia, and in particular, decrease the analgesic effect 
of opiates. Therefore, we tested the hypothesis that the sexually dimorphic effects of morphine 
were due to sex differences in glial cell activity. Our studies focused on the midbrain 
periaqueductal gray (PAG) as this region of the brain is critical for the analgesic effects of 
morphine. Adult male and female Sprague Dawley rats (250g- 400g) were procured from 
Charles River Laboratories, and were allowed 7 days to acclimate to the new facility. On the day 
of the experiment, animals received a subcutaneous injection of morphine (5mg/kg) or were 
handled in a similar manner. Thirty or 60 minutes after injections or handling, animals were 
perfused with a 4% paraformaldehyde and 2.5% acrolein tissue fixative solution. Brains were 
removed and stored in 20% sucrose until ready for sectioning. Brains were sectioned at 25µm 
using a freezing microtome, and immunohistochemical localization of markers for astrocyte glial 
cell activity was performed. Antibodies to glial fibrillary acidic protein (GFAP) were used to 
label activated astrocytes. If our hypothesis is correct, then females will have significantly 
greater density of the astrocyte cell activity marker GFAP as compared with males.  Sex 
differences in PAG glial cell activity may provide the biological bases for the sexually dimorphic 
effect of morphine. This research may lead to better treatment for females experiencing 
prolonged chronic or neuropathic pain. 
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1 
INTRODUCTION 
 
Morphine is one of the most commonly prescribed drugs for the relief of prolonged pain.  
Morphine does not produce the same degree of analgesia in males as compared to females 
(Kepler et al., 1989; Cicero et al., 1996). Previous work in our lab has shown that females 
require 2-3 times more morphine to produce the same analgesic effect as males (Fig 1; Wang et 
al., 2006.). To date, the mechanisms underlying sex differences in opiate responsiveness are 
unknown. The periaqueductal gray (PAG) is a brain region that has been shown to be important 
for the analgesic effects of morphine (Loyd and Murphy, 2008). The PAG sends extensive 
projections to the rostral ventromedial medulla (RVM) of the brainstem, which in turn sends 
descending projections to the dorsal horn of the spinal cord. The PAG-RVM-spinal cord pathway 
is an essential circuit for antinociception (A.I Basbaum et al., 1978; H.L Fields et al., 1991). 
These regions also contain a high density of mu opioids receptors (MOR) (Loyd et al., 2007).  
Opioids modulate pain by binding to the mu opioid receptor in the ventrolateral PAG (vlPAG). 
vlPAG projection neurons excite cells in the rostral ventromedial medulla (RVM) that project to 
the dorsal horn of the spinal cord (Fig 2: Loyd and Murphy, 2008) where they inhibit incoming 
pain signals.  
Recent studies suggest that glial cells are potent modulators of morphine-based analgesia. In 
particular, several studies have now shown that glial cells decrease the analgesic effect of opiates 
(Hao et al., 2011; Wei et al., 2012). The two primary glia cells involved in this phenomenon are 
astrocytes and microglia. Microglia are shown to be the first responders to even minor 
pathological changes in the CNS (Kreutzberg G.W., 1996). Activation of these cells is a key 
factor in the defense against brain tumors, infectious diseases, inflammation, ischaemia, trauma, 
and neurodegeneration (Kreutzberg G.W., 1996). Astrocytes have also been implicated in the 
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proinflamatory response to injuy (Hao et al., 2011; Wei et al., 2012). Recent studies by our lab 
show that both microglia and astrocyte activity within the PAG increases in response to 
morphine (Fig 3 & 4: Eidson & Murphy; under review). As increased levels of glia activity are 
associated with decreased morphine analgesia, we tested the hypothesis that the sexually 
dimorphic effects of morphine were due to sex differences in glial cell activity within the vlPAG.  
If our hypothesis is correct, then administration of morphine to females should result in 
significantly higher levels of astrocyte activation as compared to males. For these studies we 
used immunohistochemistry to label glial fibrillary acidic protein (GFAP). GFAP is a commonly 
used marker of astrocyte activity, as it has been shown to correlate with a change in morphology 
and release of proinflammatory cytokines, indicative of an active phenotype (Raghavendra et al., 
2004). Sex differences in vlPAG glial cell activity may provide the biological bases for the 
sexually dimorphic effect of morphine. Given the strong evidence indicating that glial cell 
activity prevents morphine from being an effective analgesic, this research may lead to better 
treatment for females experiencing prolonged, chronic, or neuropathic pain.  
 
 
Materials and Methods 
 
Subjects.  Aged matched adult male and female (2 months; 150-350g) Sprague-Dawley rats 
(Charles River Laboratories; USA) were procured and were allowed 7 days to acclimate to the 
new facility. Same-sex rats were pair-housed in separate rooms with 12:12 hour light: dark cycle 
(lights on at 8:00A.M.). Vaginal lavages were taken, and vaginal cytology was analyzed daily (for 
2-3 weeks) to ensure that females were cycling normally, and to determine the stage of the 
estrous cycle the rats were in on the day of sacrifice. Rats had access to food and water ad 
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libitum throughout the experiment. These studies were done in accordance with the Georgia State 
University Animal Care and Use Committee (IACUC). 
Morphine Administration.  Adult male and female Sprague Dawley rats were administered 
morphine sulfate (experimental group) in 0.9% sterile saline (5 mg/kg, sc; NIDA; Bethesda, MD) 
or were restrained in a similar manner (handled control). Following morphine administration, 
animals were placed back into their home cage until sacrifice. 
Perfusion.  The handled control and morphine groups were further assigned to two groups.  The 
first group received a lethal dose of sodium pentobarbital (60mg/kg; ip) 15 mins after injection 
or handling. The second group was euthanized 60 mins following morphine administration. The 
animal was confirmed to be unconscious and was perfused transcardially with 200 ml of 0.9% 
sodium chloride containing 2% sodium nitrite solution to clear the blood from brain. Following 
the saline, brains were immediately fixed by perfusing 150 ml of 4% aqueous paraformaldehyde 
fixative solution containing 2.5% acrolein (Polysciences Inc.; Warrington, PA) into the heart. 
The fixative was rinsed using 200 ml of 0.9% sodium chloride/sodium nitrite solution. 
Immediately after perfusion, brains were removed and stored in a 30% sucrose solution at 4 C 
until the time of sectioning (at least 24 hours). Brains were coronally sectioned using a freezing 
microtome (Leica 2000R) at 25µm and stored in cryoprotectant solution (Watson et al., 1986) at 
-20 C until immunohistochemical staining.  
Immunohistochemistry.  Glial cell activity was localized to the vlPAG region. Tissue samples 
were rinsed in potassium phosphate buffer saline solution (KPBS) to remove cryoprotectant 
solution. Tissue was then incubated for 20 min in 1% sodium borohydride in KPBS. Astrocyte 
activity levels were determined by incubating the tissue samples in primary antibody, glial 
fibrillary acidic protein (GFAP), for one hour at room temperature followed by 48 hours at 4 C. 
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Rabbit α-GFAP (Abcam, 1:5000 for 3,3’-diaminobenzidine reaction, and 1:3000 for 
fluorescence) in KPBS containing 1% Triton-X solution. The primary antibody was washed out 
with KPBS, and the tissue was incubated for one hour in biotinylated goat anti-rabbit IgG 
secondary antibody (Jackson Immunoresearch, 1:600). Tissue was rinsed in KPBS and incubated 
in avindin-biotin peroxidase complex (ABC Elite Kit, Vector labs). Following rinsing in KPBS 
and sodium acetate solution (0.175M; pH 6.5), GFAP reactivity was visualized as a black 
chromagen reaction product using 3, 3’- diaminobenzidine solution containing nickel sulfate and 
0.8% hydrogen peroxide in sodium acetate buffer. The reaction was terminated using three rinses 
of sodium acetate buffer. Sections were sorted to rostral-caudal levels, mounted onto gelatin-
subbed slides, and allowed to air dry (at least 10 h). Tissue was dehydrated in a graded series of 
ethanol solutions, cleared in xylenes and cover-slipped using Permount.    
Densitometry.  Previous studies have shown that the PAG is not a homogenous structure (Van 
Bockstaele et al. 1991, Bandler et al., 1994). In this study the densitometry of GFAP staining 
was determined for four rostro-caudal levels of PAG (Bregma -6.24, -6.72, -7.04, -8.00). GFAP 
immunoreactivity in the vlPAG was compared across treatment groups using previously 
described semi-quantitative densitometry (loyd et al., 2008, Laprairie et al., 2009). Images, 12-
bit grayscale, including the region of interest (ROI) were captured using a QImaging Retiga EXi 
CCD camera (Surrey, BC, Canada) and iVision Image analysis software (Biovision 
Technologies, Exton, PA). Grayscale values were inverted for each image so that higher values 
represent increased staining levels. Drawing tools were used in iVision to outline the ROI for 
data sampling, and using the “measure” function determine an average grayscale pixel value for 
the outlined area. Values were corrected for nonspecific binding by subtracting an adjacent 
measure of gray matter in the ROI to represent background. Densitometry values are presented 
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as mean ± S.E.M. Analysis of variance (ANOVA) was used to test for significant main effects of 
sex (male, female), PAG level (Bregma –6.24 through −8.00); treatment (Handled, sc morphine 
15 min, sc morphine 60 min) where relevant. P≤0.05 was considered significant for all analyses. 
RESULTS 
Male and female vlPAG GFAP immunoreactivity increased in a similar pattern in response to 
morphine, with no significant differences noted at different Bregma levels within vlPAG region 
(Fig 4). There was a significant main effect of treatment (handled v. morphine; ANOVA: F
 (2, 24) 
= 5.767; p= 0.009). Post-hoc analysis revealed that 60 minutes of morphine increased vlPAG 
astrocyte activity as compared with handled controls (t-test; p= 0.0131), and sc morphine 15 
minute (t-test; p= 0.0136) in both males and females. There was no significant difference 
between the handled and sc morphine 15 groups (t-test; p=0.6204). There was not a significant 
main effect of sex (ANOVA: F
 (1, 24) = 0.148; p=0.7034), and no significant interaction (ANOVA: 
F
 (2, 24) = 0.079; p=0.9245).  
 
DISCUSSION 
 
Recent studies suggest that glial cells are potent modulators of morphine-based analgesia, and in 
particular, decrease the analgesic effect of opiates (Raghavendra et al., 2002, Wei et al., 2008, 
Watkins et al., 2001). Morphine acts through the PAG-RVM pathway to produce analgesia. The 
results of our study indicate that morphine does not differentially activate vlPAG astrocytes in 
male and female rats. Indeed, both males and females showed a similar activation pattern in 
response to morphine. Administration of morphine resulted in a 2 fold increase in activation at 
60 mins as compared to handled. Consistent with previous work done in our lab, morphine 
causes increased vlPAG glial cell activity in males (Eidson & Murphy; under review). Our 
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hypothesis that female rats have increased glial cell activation in the vlPAG as compared with 
males was not supported. In future studies, microglial cell number and function will be 
determined within the PAG. Microglia have also been shown to inhibit morphine analgesia (Guo 
et al, 2012).  
Morphine causes the activation of glia and leads to the release and upregulation of 
proinflammatory cytokines (Johnston et al., 2004) that oppose morphine analgesia (Raghavendra 
et al., 2002, Watkins et al., 2001, Hutchinson et al., 2008). Cytokines, or more specifically tumor 
necrosis factor alpha (TNFα), have been shown to suppress morphine analgesia (Hao et al., 
2011). Studies of the role of cytokines in response to morphine analgesia in both the male and 
female models could also prove to be beneficial in better understanding mechanisms of vlPAG 
glial cell activity. 
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FIGURES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. The antinociceptive response to different morphine dosage, expressed 
as %MPE, in male and female CFA-treated rats (N = 54). PWL were 
measured for each dosage. A light cut off of 20 sec was implemented to 
reduce possible harm to animals. P < 0.05 for male-female comparison was 
used. 
       Rostral Ventromedial 
Medulla 
Fig. 2. A schematic of the neuronal projections from the midbrain 
periaqueductal gray to the brainstem RVM and spinal cord dorsal horn 
illustrating the descending pain pathway.  
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Fig. 3. Glial fibrillary acidic protein (GFAP) florescent-immunoreactive vlPAG of male 
rats. Animals were either administered A. s.c saline (5ml/kg) or B. s.c morphine (5mg/kg). 
  
A. B. 
Fig. 4. Glial fibrillary acidic protein (GFAP) -immunoreactive 
cells in the midbrain periaqueductal gray (PAG) of male rats. 
Values are expressed as the mean ± SEM percentage of all 
levels. Animals were either administered s.c saline (5ml/kg) or 
s.c morphine (5mg/kg). 
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Fig. 5. Glial fibrillary acidic protein (GFAP) -immunoreactive cells in 
the midbrain periaqueductal gray (PAG) of male and female rats. 
Values are expressed as the mean ± SEM percentage of all levels. 
Animals were either administered s.c morphine (5mg/kg) or were 
handled. Both treatment groups were perfused either 15 min or 30 min 
after treatment.  
  
Fig. 6. Glial fibrillary acidic protein (GFAP) immunoreactive cells in the 
midbrain periaqueductal gray (PAG). Representative PAG images from Sprague-
Dawley rats. A. Handled male B. s.c morphine (5mg/kg) male C. handled female 
female D. s.c morphine (5mg/kg) female. Animals were perfused 15 or 30 min 
after treatment. 
A
. 
B. 
C. D
. 
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